Ahead of Rare Disease Day 2024, we travelled to New Zealand to participate in the official launch of the latest Impact of Living with a Rare Disorder in New Zealand.
Ahead of Rare Disease Day 2024, we travelled to New Zealand to participate in the official launch of the latest Impact of Living with a Rare Disorder in New Zealand.
For Rare Disease Day 2024, we travelled to New Zealand to advocate for the Immune Thrombocytopenia community. While there, we joined the Rare Disorders New Zealand Support Group breakfast.
Meet Luca. He’s a force to be reckoned with, and in the last couple of years since meeting him, he’s used his voice to help raise awareness of Immune Thrombocytopenia.
Meet the latest member of our Medical Advisory Board, Professor Elizabeth Gardiner and recently appointed Director of the John Curtin School of Medical Research at The Australian National University in Canberra.
Written by Dr Cindy Neunert, Paediatric Hematologist & Medical Advisor
The first week of December, when the American Society of Hematology (ASH) holds its annual meeting, is always a busy time for hematologists.
Dr. Terry Gersheimer stands as a shining example in the field of immune thrombocytopenia (ITP) research, earning the esteemed Robert McMillan Award in 2023.
Professor James Bussel received the Henry M. Stratton Medal for Clinical/Transitional science at the 2023 American Society of Hematology Conference in San Diego, California.
During November 2023, ITP Australia and New Zealand participated in the annual Haematology Conference, Blood 2023, held in Melbourne, Victoria. This marked the organisation’s third consecutive year with a presence in the Exhibition Hall alongside other non-profit organisations.
Leading ITP clinicians come together and deliver consensus guidelines for the treatment of (ITP) in adult patients.